Home/ Supplements/ Vitamin K/ Vitamin K2 as MK-7 100 mcg

Vitamin K2 as MK-7 100 mcg

product on market Softgel Capsule Healthy Origins Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 as MK-7 supports calcium homeostasis by regulating proteins that direct calcium into bones and away from arteries. There is moderate research evidence suggesting its role in improving bone density and cardiovascular health. This specific formulation maintains a high safety profile for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 as MK-7 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
180
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Vegetarian Softgel organic extra virgin Olive Oil yellow Beeswax Sunflower Lecithin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take one (1) veggie softgel daily, or as recommended by a physician.

Warnings & Precautions

Keep out of reach of children

Caution: Consult a physician before use if you are pregnant, nursing, taking medication or have a medical condition.

Formulation Notes

Healthy Origins Vitamin K2 (from Natto) provides vitamin K2 in its most biologically active form called Menaquinone-7 or MK-7 for short. Vitamin K2 as MK-7 has superior absorption and retention in the body when compared to vitamin K1 - the typical supplemental form. Natural Vitamin K2 may help to support bone health, cardiovascular health, calcium metabolism and arterial health.

Natural Supports bone & cardiovascular health

Suitable for vegetarians

Non GMO Not manufactured with wheat, gluten, soy, milk, egg, fish, shellfish, peanut, or tree nut derived ingredients.

Manufactured in a cGMP facility.

Additional Information

Store in a cool, dry place.

New look

3rd party tested

Metadata

Product Details

UPC / SKU6 03573 27446 7
DSLD Entry Date2022-06-16
Product TypeVitamin
FormSoftgel Capsule
DSLD ID269175
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.